387 related articles for article (PubMed ID: 18356410)
1. RhoA/Rho-kinase contribute to the pathogenesis of diabetic renal disease.
Peng F; Wu D; Gao B; Ingram AJ; Zhang B; Chorneyko K; McKenzie R; Krepinsky JC
Diabetes; 2008 Jun; 57(6):1683-92. PubMed ID: 18356410
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway.
Thallas-Bonke V; Thorpe SR; Coughlan MT; Fukami K; Yap FY; Sourris KC; Penfold SA; Bach LA; Cooper ME; Forbes JM
Diabetes; 2008 Feb; 57(2):460-9. PubMed ID: 17959934
[TBL] [Abstract][Full Text] [Related]
3. Activation of RhoA/ROCK regulates NF-κB signaling pathway in experimental diabetic nephropathy.
Xie X; Peng J; Chang X; Huang K; Huang J; Wang S; Shen X; Liu P; Huang H
Mol Cell Endocrinol; 2013 Apr; 369(1-2):86-97. PubMed ID: 23376009
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells.
Itoh Y; Kimoto K; Imaizumi M; Nakatsuka K
Exp Eye Res; 2007 Mar; 84(3):464-72. PubMed ID: 17217948
[TBL] [Abstract][Full Text] [Related]
5. Role of inducible nitric oxide synthase in induction of RhoA expression in hearts from diabetic rats.
Soliman H; Craig GP; Nagareddy P; Yuen VG; Lin G; Kumar U; McNeill JH; Macleod KM
Cardiovasc Res; 2008 Jul; 79(2):322-30. PubMed ID: 18411229
[TBL] [Abstract][Full Text] [Related]
6. BXL-628, a vitamin D receptor agonist effective in benign prostatic hyperplasia treatment, prevents RhoA activation and inhibits RhoA/Rho kinase signaling in rat and human bladder.
Morelli A; Vignozzi L; Filippi S; Vannelli GB; Ambrosini S; Mancina R; Crescioli C; Donati S; Fibbi B; Colli E; Adorini L; Maggi M
Prostate; 2007 Feb; 67(3):234-47. PubMed ID: 17163492
[TBL] [Abstract][Full Text] [Related]
7. Defective RhoA/Rho-kinase signaling contributes to vascular hypocontractility and vasodilation in cirrhotic rats.
Hennenberg M; Biecker E; Trebicka J; Jochem K; Zhou Q; Schmidt M; Jakobs KH; Sauerbruch T; Heller J
Gastroenterology; 2006 Mar; 130(3):838-54. PubMed ID: 16530523
[TBL] [Abstract][Full Text] [Related]
8. Berberine ameliorates experimental diabetes-induced renal inflammation and fibronectin by inhibiting the activation of RhoA/ROCK signaling.
Xie X; Chang X; Chen L; Huang K; Huang J; Wang S; Shen X; Liu P; Huang H
Mol Cell Endocrinol; 2013 Dec; 381(1-2):56-65. PubMed ID: 23896433
[TBL] [Abstract][Full Text] [Related]
9. RhoA/Rho kinase signaling in the spinal cord and diabetic painful neuropathy.
Ohsawa M; Kamei J
Eur J Pharmacol; 2010 Oct; 644(1-3):1-4. PubMed ID: 20655903
[TBL] [Abstract][Full Text] [Related]
10. SREBP-1 activation by glucose mediates TGF-β upregulation in mesangial cells.
Uttarwar L; Gao B; Ingram AJ; Krepinsky JC
Am J Physiol Renal Physiol; 2012 Feb; 302(3):F329-41. PubMed ID: 22031849
[TBL] [Abstract][Full Text] [Related]
11. Thrombospondin-1 is an endogenous activator of TGF-beta in experimental diabetic nephropathy in vivo.
Daniel C; Schaub K; Amann K; Lawler J; Hugo C
Diabetes; 2007 Dec; 56(12):2982-9. PubMed ID: 17878288
[TBL] [Abstract][Full Text] [Related]
12. A potential role for caveolin-1 in VEGF-induced fibronectin upregulation in mesangial cells: involvement of VEGFR2 and Src.
Wu T; Zhang B; Ye F; Xiao Z
Am J Physiol Renal Physiol; 2013 Mar; 304(6):F820-30. PubMed ID: 23269647
[TBL] [Abstract][Full Text] [Related]
13. Role of growth arrest-specific gene 6 in diabetic nephropathy.
Arai H; Nagai K; Doi T
Vitam Horm; 2008; 78():375-92. PubMed ID: 18374201
[TBL] [Abstract][Full Text] [Related]
14. Targeting of RhoA/ROCK signaling ameliorates progression of diabetic nephropathy independent of glucose control.
Kolavennu V; Zeng L; Peng H; Wang Y; Danesh FR
Diabetes; 2008 Mar; 57(3):714-23. PubMed ID: 18083785
[TBL] [Abstract][Full Text] [Related]
15. Akt and RhoA activation in response to high glucose require caveolin-1 phosphorylation in mesangial cells.
Wu SZ; Peng FF; Li JL; Ye F; Lei SQ; Zhang BF
Am J Physiol Renal Physiol; 2014 Jun; 306(11):F1308-17. PubMed ID: 24694591
[TBL] [Abstract][Full Text] [Related]
16. Modulation of RhoA-Rho kinase-mediated Ca2+ sensitization of rabbit myometrium during pregnancy - role of Rnd3.
Cario-Toumaniantz C; Reillaudoux G; Sauzeau V; Heutte F; Vaillant N; Finet M; Chardin P; Loirand G; Pacaud P
J Physiol; 2003 Oct; 552(Pt 2):403-13. PubMed ID: 14561824
[TBL] [Abstract][Full Text] [Related]
17. High glucose-induced upregulation of Rho/Rho-kinase via platelet-derived growth factor receptor-beta increases migration of aortic smooth muscle cells.
Akiyama N; Naruse K; Kobayashi Y; Nakamura N; Hamada Y; Nakashima E; Matsubara T; Oiso Y; Nakamura J
J Mol Cell Cardiol; 2008 Aug; 45(2):326-32. PubMed ID: 18561944
[TBL] [Abstract][Full Text] [Related]
18. Fluvastatin inhibits activation of JAK and STAT proteins in diabetic rat glomeruli and mesangial cells under high glucose conditions.
Shi YH; Zhao S; Wang C; Li Y; Duan HJ
Acta Pharmacol Sin; 2007 Dec; 28(12):1938-46. PubMed ID: 18031608
[TBL] [Abstract][Full Text] [Related]
19. Mechanical stretch-induced RhoA activation is mediated by the RhoGEF Vav2 in mesangial cells.
Peng F; Zhang B; Ingram AJ; Gao B; Zhang Y; Krepinsky JC
Cell Signal; 2010 Jan; 22(1):34-40. PubMed ID: 19755152
[TBL] [Abstract][Full Text] [Related]
20. Effects of p38 mitogen-activated protein kinase inhibition on blood pressure, renal hemodynamics, and renal vascular reactivity in normal and diabetic rats.
Komers R; Schutzer W; Xue H; Oyama TT; Lindsley JN; Anderson S
Transl Res; 2007 Dec; 150(6):343-9. PubMed ID: 18022596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
